Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals. (2022)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1128/mbio.03798-21
PubMed Identifier: 35297676
Publication URI: http://europepmc.org/abstract/MED/35297676
Type: Journal Article/Review
Volume: 13
Parent Publication: mBio
Issue: 2